Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Acute respiratory infections (ARIs) are a common cause of illness in children younger than 16 years and adults older than 65 ...

WHEN a 44-year-old man began experiencing a common symptom experienced by millions, he decided to get checked out by medical ...

Regular walking, even in small amounts, can greatly enhance longevity and overall health, according to recent studies ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Effective management of type 2 diabetes often requires a combination of medication, regular physical activity, changes in diet, weight loss, and blood sugar monitoring. Research has also suggested ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Roughly 60 000 South Africans die in a year from diseases that are not caused by an infection such as tuberculosis (TB) or HIV — before they turn 70. About a fifth of these deaths are from diabetes, ...

Lexicon (LXRX) announced The Lancet Diabetes & Endocrinology has published a research paper analyzing the ability of sotagliflozin, a dual ...

The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...